Department of Oto-Rhino-Laryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Int Forum Allergy Rhinol. 2014 Apr;4(4):339-44. doi: 10.1002/alr.21278. Epub 2014 Jan 10.
Radiofrequency volumetric tissue reduction (RFVTR) of hypertrophic inferior turbinate (IT) is an effective way to treat patients with intractable nasal mucosal obstruction. We evaluated the effectiveness of combined RFVTR and lateral outfracture (LO) of hypertrophic IT in chronic rhinitis (CR) patients on reduction of nasal obstruction, rhinorrhea, and nasal pruritus both short and long term.
Seventy-three patients with CR who failed medical treatment were recruited to undergo combined RFVTR and LO of hypertrophic IT. Nasal congestion scores were recorded before the operation, and immediately, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years, and 3 years after the operation. Rhinorrhea and pruritic score as well as total nasal airway resistance (TNAR) and total nasal airflow (TNAF) (measured by active anterior rhinomanometry) were recorded before the operation, and 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years, and 3 years after the operation.
Forty-five patients completed the follow-up period of 3 years. Subjects consisted of 25 male and 20 female patients, with an average age of 31 years. Nasal congestion scores were significantly improved immediately after the operation. Nasal congestion scores and TNAR values were significantly decreased whereas TNAF values were significantly increased at every time point postoperatively. Rhinorrhea and pruritic scores were also significantly improved at every time point after 2 weeks postoperatively.
Combined RFVTR and LO of hypertrophic IT is an effective treatment for nasal obstruction, rhinorrhea, and nasal pruritus in CR and the result lasts up to 3 years postoperatively.
射频鼻甲容积减少术(RFVTR)治疗肥厚性下鼻甲(IT)是治疗难治性鼻黏膜阻塞患者的有效方法。我们评估了 RFVTR 联合下鼻甲外侧骨折术(LO)治疗慢性鼻炎(CR)患者鼻甲肥厚导致的鼻塞、流涕和鼻痒的短期和长期疗效。
招募了 73 例经药物治疗失败的 CR 患者,行 RFVTR 联合下鼻甲 LO。记录术前、术后即刻、术后 2 周、6 周、3 个月、6 个月、1 年、2 年和 3 年的鼻塞评分。术前及术后 2 周、6 周、3 个月、6 个月、1 年、2 年和 3 年记录流涕和鼻痒评分以及总鼻气道阻力(TNAR)和总鼻气流(TNAF)(主动前鼻测压法测量)。
45 例患者完成了 3 年的随访。入组患者包括 25 例男性和 20 例女性,平均年龄 31 岁。术后即刻鼻塞评分明显改善。术后各时间点,鼻塞评分和 TNAR 值均显著降低,而 TNAF 值显著升高。术后 2 周后,流涕和鼻痒评分也显著改善。
RFVTR 联合下鼻甲 LO 治疗 CR 患者的鼻塞、流涕和鼻痒是有效的,疗效可维持 3 年以上。